Benzo[D]Isoxazole

Benzo[D]Isoxazole

SCHEMBL5158032

[N].c1ccc2oncc2c1

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 4/20 0.34
CA12 O43570 3/20 0.33
CA9 Q16790 3/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
CYP2A6 P11509 2/20 0.33
CA1 P00915 2/20 0.33
CA3 P07451 2/20 0.33
CA4 P22748 2/20 0.33
CA6 P23280 2/20 0.33
CA5A P35218 2/20 0.33
CA7 P43166 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
CA14 Q9ULX7 2/20 0.33
CA5B Q9Y2D0 2/20 0.33
ALOX12 P18054 1/20 0.33
CA2 P00918 1/20 0.33
LMNA P02545 1/20 0.33
MCL1 Q07820 1/20 0.33
SOST Q9BQB4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzo[D]Isoxazole SCHEMBL8438 0.97
Benzo[D]Isoxazole SCHEMBL29366929 0.97
Benzo[D]Isoxazole SCHEMBL1355530 0.97
Benzo[D]Isoxazole SCHEMBL1982876 0.95 TDO2 (0.34) TDO2CA12CA9NPC1RAB9A
Benzo[D]Isoxazole SCHEMBL29184280 0.95 TDO2 (0.34) TDO2CA12CA9NPC1RAB9A
Benzo[D]Isoxazole SCHEMBL5778868 0.95 TDO2 (0.34) TDO2CA12CA9NPC1RAB9A
Benzo[D]Isoxazole SCHEMBL21596877 0.95 TDO2 (0.34) TDO2CA12CA9NPC1RAB9A
Benzo[D]Isoxazole SCHEMBL28482344 0.95 TDO2 (0.39) TDO2CA12CA9NPC1RAB9A
Benzo[D]Isoxazole SCHEMBL28915250 0.87 LMNA (0.37) TDO2NPC1RAB9ALMNAMAPT
Benzo[D]Isoxazole SCHEMBL6649129 0.87 MAPK1 (0.33) TDO2NPC1RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197610-A1 Benzisoxazoles JANSSEN PHARMACEUTICA N.V. 2007-08-23 US disclosed
EP-1746991-A2 DAAO INHIBITING BENZISOXAZOLES FOR TREATING MENTAL DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-31 EP disclosed
WO-2005089753-A2 DAAO INHIBITING BΞNZISOXAZOLES AND THEIR USE FOR THE TREATMENT OF MENTAL DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 2005-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197610-A1 Benzisoxazoles NR4A1, OXER1, NR0B1 TDO2 1428/4885CA12 4652/4885CA9 2975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.